Reversible splenial lesion in new-onset refractory status epilepticus: A case report

Clin Neurol Neurosurg. 2019 Aug:183:105392. doi: 10.1016/j.clineuro.2019.105392. Epub 2019 Jun 20.

Abstract

A 33-year-old man developed a generalized tonic-clonic seizure after a week of fever and fatigue. Diffusion weighted and fluid attenuated inversion recovery magnetic resonance imaging showed a hyperintense lesion in the splenium of the corpus callosum, and the lesion disappeared within a few days. The patient developed refractory status epilepticus despite treatment with multiple antiepileptic drugs. After concurrent administration of high-dose methylprednisolone, intravenous immunoglobulin, intravenous anesthetics and antiepileptic drugs, the patient achieved complete suppression of seizures. To the best of our knowledge, this is the first case of a new-onset refractory status epilepticus with a reversible splenial lesion.

Keywords: New-onset refractory status epilepticus; Reversible splenial lesion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticonvulsants
  • Corpus Callosum / pathology*
  • Encephalitis / diagnosis
  • Encephalitis / pathology*
  • Humans
  • Male
  • Paraspinal Muscles / pathology
  • Seizures / diagnosis
  • Seizures / pathology*
  • Seizures / surgery
  • Status Epilepticus / diagnosis
  • Status Epilepticus / pathology*

Substances

  • Anticonvulsants